Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sharon

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Journal of the American Academy of Dermatology|March 11, 2020
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adultsLucia Seminario-Vidal, Daniela Kroshinsky, Stephen J Malachowski, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
Science (New York, N.Y.)|February 20, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequencesMaxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 1, 2021
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
JAMA Pediatrics|February 9, 2026
Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-AnalysisNazmul Islam, Alexandro W L Chu, Falana Sheriff, et al.
The Journal of Investigative Dermatology|May 15, 2018
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United StatesRobert G Micheletti, Zelma Chiesa-Fuxench, Megan H Noe, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
The World Allergy Organization Journal|March 13, 2023
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)Stefania Arasi, Ulugbek Nurmatov, Audrey Dunn-Galvin, et al.
Clinical and Translational Allergy|November 29, 2024
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis ManifestoAntonella Muraro, Debra de Silva, Marcia Podesta, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Journal of the American Academy of Dermatology|March 11, 2020
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adultsLucia Seminario-Vidal, Daniela Kroshinsky, Stephen J Malachowski, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
Science (New York, N.Y.)|February 20, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequencesMaxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 1, 2021
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
JAMA Pediatrics|February 9, 2026
Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-AnalysisNazmul Islam, Alexandro W L Chu, Falana Sheriff, et al.
The Journal of Investigative Dermatology|May 15, 2018
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United StatesRobert G Micheletti, Zelma Chiesa-Fuxench, Megan H Noe, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
The World Allergy Organization Journal|March 13, 2023
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)Stefania Arasi, Ulugbek Nurmatov, Audrey Dunn-Galvin, et al.
Clinical and Translational Allergy|November 29, 2024
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis ManifestoAntonella Muraro, Debra de Silva, Marcia Podesta, et al.
Pageof 30